ROCKVILLE, Md., March 09, 2016 (GLOBE NEWSWIRE) — Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the 28th Annual ROTH Conference on Tuesday, March 15, 2016 at 7:00 AM PT or 10:00 AM ET.
Investors interested in arranging a meeting with the Company’s management during this conference should contact the conference coordinator.
The presentation will be webcast live and may be accessed from the Event Calendar page of Sucampo’s website at http://www.sucampo.com/investors/events-presentations/. A replay of the webcast will also be available on the Company’s website for several days after the live event. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has one marketed product – AMITIZA – and a pipeline of product candidates in clinical development. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K. For more information, please visit www.sucampo.com.
The Sucampo logo and the tagline, The Science of Innovation, are registered trademarks of Sucampo AG. AMITIZA is a registered trademark of Sucampo AG.
Follow us on Twitter (@Sucampo_Pharma). Follow us on LinkedIn (Sucampo Pharmaceuticals).
Contact:Sucampo Pharmaceuticals, Inc.Silvia TaylorSenior Vice President, Investor Relations and Corporate Affairs1firstname.lastname@example.org Sucampo Pharmaceuticals Inc